These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35935324)
1. Study on the Expression of lncRNA ATB and Nek9 in Breast Cancer Patients Based on Q-PCR Technology and Its Relationship with the Disease. Zhaoyu Z; Huanyu X; Yajie Z; Ziyu D; Hui L; Feng S Contrast Media Mol Imaging; 2022; 2022():2634080. PubMed ID: 35935324 [TBL] [Abstract][Full Text] [Related]
2. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer. El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer. Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611 [TBL] [Abstract][Full Text] [Related]
4. Expression analysis of long non-coding ATB and its putative target in breast cancer. Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827 [TBL] [Abstract][Full Text] [Related]
5. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Iguchi T; Uchi R; Nambara S; Saito T; Komatsu H; Hirata H; Ueda M; Sakimura S; Takano Y; Kurashige J; Shinden Y; Eguchi H; Sugimachi K; Maehara Y; Mimori K Anticancer Res; 2015 Mar; 35(3):1385-8. PubMed ID: 25750289 [TBL] [Abstract][Full Text] [Related]
6. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis. Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301 [TBL] [Abstract][Full Text] [Related]
7. Expression of lncRNA-ATB in laryngeal carcinoma and its relationship with prognosis. Huang DN; Liu HW; Li ZD Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11148-11153. PubMed ID: 33215432 [TBL] [Abstract][Full Text] [Related]
8. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
9. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer. Ke L; Xu SB; Wang J; Jiang XL; Xu MQ Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value and pathogenetic role of lncRNA-ATB in patients with osteoarthritis. Dang X; Lian L; Wu D Cell Mol Biol Lett; 2018; 23():55. PubMed ID: 30505322 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer. Cao W; Peng T; Zhou Y J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA activated by transforming growth factor-β promotes proliferation and invasion of cervical cancer cells by regulating the miR-144/ITGA6 axis. Zhu Y; Wu Y; Yang L; Dou X; Jiang J; Wang L Exp Physiol; 2019 Jun; 104(6):837-844. PubMed ID: 30908730 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis. Cheng XB; Fu B; Li XZ; Jiang Y Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201 [TBL] [Abstract][Full Text] [Related]
14. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma. Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875 [TBL] [Abstract][Full Text] [Related]
15. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway. Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of lncRNA-ATB expression in malignant solid tumors: A meta-analysis. Wang B; Lu Z; Huang Y; Lin T Pathol Res Pract; 2020 Apr; 216(4):152897. PubMed ID: 32146004 [TBL] [Abstract][Full Text] [Related]
18. The function of LncRNA-ATB in cancer. Anbiyaiee A; Ramazii M; Bajestani SS; Meybodi SM; Keivan M; Khoshnam SE; Farzaneh M Clin Transl Oncol; 2023 Jan; 25(1):1-9. PubMed ID: 35597865 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells. Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]